SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-04-005379
Filing Date
2004-11-15
Accepted
2004-11-15 16:37:26
Documents
5
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b52053ape10vq.htm 10-Q 325728
2 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b52053apexv31w1.txt EX-31.1 3489
3 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b52053apexv31w2.txt EX-31.2 3360
4 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. b52053apexv32w1.txt EX-32.1 1273
5 EX-32.2 SECTION 906 CERTIFICATION OF C.F.O. b52053apexv32w2.txt EX-32.2 1250
  Complete submission text file 0000950135-04-005379.txt   337272
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 041145886
SIC: 2834 Pharmaceutical Preparations